ADUS
Addus HomeCare Corporation
ADUS has slightly lower modeled downside risk, despite its lower overall score.
LLY
Eli Lilly and Company
LLY has the edge over ADUS overall, supported by stronger fundamentals and stronger modeled upside.
ADUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ADUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
ADUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $124 | — |
| Current | 21x | $124 | — |
| Cheap | 24x | $146 | +18% |
| Fair | 30x | $180 | +46% |
| Expensive | 48x | $286 | +131% |
Historical ranges are pointers, not guarantees.
ADUS has the edge over LLY in the historical PE scenario, which offers more potential upside but is not a forecast.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
ADUS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ADUS, with profitability holding steady.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over ADUS on the outlook, with more favorable profitability expectations.
ADUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.47 | +24% |
| Q3 2026 | $6.01 | +29% |
| Q2 2026 | $5.71 | +26% |
| Q1 2026 | $5.42 | +23% |
| Q4 2025 | $5.22 | +23% |
| Q3 2025 | $4.66 | +6.9% |
| Q2 2025 | $4.52 | +7.4% |
| Q1 2025 | $4.42 | +10% |
| Q4 2024 | $4.23 | +10% |
ADUS's earnings per share have climbed steadily: $6.01 over the past year, up 29% from the year before, and higher year over year every quarter since late 2020.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over ADUS on earnings, with stronger typical year-over-year growth.
ADUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $387.7M | +7% |
| Q2 2026 | $377.4M | +8% |
| Q1 2026 | $363.6M | +7.7% |
| Q4 2025 | $373.1M | +26% |
| Q3 2025 | $362.3M | +25% |
| Q2 2025 | $349.4M | +22% |
| Q1 2025 | $337.7M | +20% |
| Q4 2024 | $297.1M | +7.5% |
ADUS's revenue has grown year over year every quarter since late 2020: $388M last quarter, up 7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | +1.2 points |
| Q2 2026 | 10% | +0.9 points |
| Q1 2026 | 9.4% | +0.3 points |
| Q4 2025 | 11% | +2.3 points |
| Q3 2025 | 9.1% | +0.1 points |
| Q2 2025 | 9.4% | +0.3 points |
| Q1 2025 | 9% | +0.6 points |
| Q4 2024 | 9.1% | -1.1 points |
ADUS's operating margin was 10% last quarter, up 1.2 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over ADUS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over ADUS on profitability, with a higher operating margin.
ADUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $38.8M | -21% |
| Q2 2026 | $38.7M | +82% |
| Q1 2026 | $50.7M | +197% |
| Q4 2025 | $16.1M | +85% |
| Q3 2025 | $49.3M | +5.9% |
| Q2 2025 | $21.3M | +20% |
| Q1 2025 | $17.1M | -54% |
| Q4 2024 | $8.7M | -65% |
ADUS generated $144M in free cash flow over the past year, up 50% from the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over ADUS on cash flow, with more consistent year-over-year improvement.
ADUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +102K shares |
| 1 year | +1% | +184K shares |
| 3 years | +14% | +2.3M shares |
| 5 years | +16% | +2.5M shares |
| Available history | +17% | +2.7M shares |
ADUS has 19M diluted shares, up 1% from a year ago.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over ADUS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
ADUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
ADUS has the edge over LLY on leverage, with a lower net debt burden relative to earnings.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
ADUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.4 | Neutral |
| Stochastic | 75.9 | Neutral |
ADUS's weekly RSI is 63 (neutral) and its Stochastic is 76 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
ADUS PE vs Healthcare Sector
| Metric | ADUS | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 26x | 20% below |
| PE % | 8 | 29 | 21 pts below |
ADUS has the edge over LLY on valuation relative to its sector.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
ADUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $118.8 | 4.2% above |
| 20 week MA | $116.7 | 6.1% above |
| 50 week MA | $107.7 | 15% above |
| 100 week MA | $110.0 | 13% above |
| 200 week MA | $106.5 | 16% above |
ADUS is in an uptrend: it's above all five of its weekly moving averages, and 16% above its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY is in an uptrend: it's above all five of its weekly moving averages, and 79% above its 200-week average.
ADUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $95.6 | $115.2 | +21% |
| 2021 | $115.2 | $93.3 | -19% |
| 2022 | $93.3 | $101.0 | +8.2% |
| 2023 | $101.0 | $92.9 | -8% |
| 2024 | $92.9 | $128.2 | +38% |
| 2025 | $128.2 | $110.2 | -14% |
| 2026 YTD | $110.2 | $123.7 | +12% |
ADUS has finished lower in three of the last six years. It's up 12% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over ADUS on returns for 2026, with the stronger performance.